The noninvasive imaging method, high resolution computed tomography (HRCT),
has been developed in animal models and applied to humans with obstructive
lung disease for assessing regional and individual airway responsiveness.
The ability to directly view airway responses during provocations such as t
racheal intubation in an asthmatic could greatly enhance our understanding
and treatment of airway hyperresponsiveness. HRCT uses increased kilovoltag
e peak (kVp) and milliamperage (mAs) settings, thin slices, high spacial fr
equency reconstruction algorithms, and small fields of view to resolve stru
ctures as small as 200 mum. Therefore, airways as small as 1-2 mm in diamet
er can be viewed and measured. HRCT is a more sensitive technique for resol
ving airway caliber changes than clinical or research methods of pulmonary
function tests. HRCT allows direct in vivo measurement of airway responsive
ness to pharmacological and physiological stress that induces bronchoconstr
iction or bronchodilation. Using HRCT, we are able to measure airway dilati
on at baseline airway tone with inhalation anesthetics, differentiate the b
ronchodilating properties of inhalational agents in airways with tone, asse
ss bronchodilating agents commonly used as premedications prior to anesthes
ia, and measure airway heterogeneity at baseline tone and their response to
a variety of stimuli. This ability of HRCT to measure airway caliber and r
esponse heterogeneity in vivo noninvasively will dramatically improve our u
nderstanding of pulmonary physiology in general and the effects of anesthet
ics on the airways specifically.